Davita Healthcare Partners Inc (DVA) 83.91

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Davita Healthcare Partners Inc (DVA) 83.91 $DVA

InsiderInsights.com Daily Round Up 4/22/15: PAY, VEEV, AGCO, OPK
InsiderInsights - at Seeking Alpha - Fri Apr 24, 11:13AM CDT

KMI: 44.34 (-0.23), MNST: 141.78 (+1.42), GE: 26.80 (-0.05), ADRO: 36.00 (-0.39), GRIF: 32.30 (+0.18), AGCO: 48.31 (-0.56), ABDC: 13.75 (-0.08), GOOG: 565.06 (+18.06), OZRK: 39.42 (-0.43), VEEV: 27.17 (-0.24), DVA: 83.91 (+0.50), OPK: 14.83 (+0.17), CDTX: 15.10 (-0.05), AKBA: 8.67 (-0.08), EBIX: 29.77 (-0.21), PAY: 35.64 (-0.48), SCHW: 30.12 (-0.38), CRM: 67.83 (-0.64)

DaVita Kidney Care is Committed to Transplant Education
PR Newswire - Thu Apr 23, 9:33AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, is recognizing the education of dialysis patients about the kidney transplantation process during April, which is "National Donate Life Month."
DVA: 83.91 (+0.50)

DaVita Way of Giving Receives National Recognition for Community Support
PR Newswire - Wed Apr 22, 5:24AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, today announced that the company received a Communitas Award for its DaVita Way of Giving program.
DVA: 83.91 (+0.50)

DaVita HealthCare Partners Inc. Announces Closing of its Cash Tender Offer for the 2020 Notes and Calls for Redemption of Untendered 2020 Notes
PR Newswire - Tue Apr 21, 3:00AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) (the "Company" today announced the closing of its previously announced tender offer to purchase for cash (the "Tender Offer" any and all of its outstanding 6 5/8% Senior Notes due 2020 (the "2020 Notes". The Tender Offer expired at 5:00 p.m., Eastern Time, on April 20, 2015 (the "Expiration Time". At the Expiration Time, valid tenders had been received with respect to approximately $599.6 million of the $775 million aggregate principal amount of the 2020 Notes outstanding.
DVA: 83.91 (+0.50)

Medicare Pay Plan Elevates Outpatient And Home Health
at Investor's Business Daily - Fri Apr 17, 3:41PM CDT
Medicare physicians aren't the only ones relieved by Congress bringing down the curtain on 17 years of recurring debates, with a $214 billion doc fix that avoided a 21% cut in reimbursement and offered some payment relief to the home health care...
KND: 24.42 (+0.02), AMSG: 65.33 (+0.04), AFAM: 47.11 (+1.80), DVA: 83.91 (+0.50), LHCG: 36.06 (+1.33), THC: 50.65 (-0.58), BKD: 37.33 (+0.59), FMS: 43.18 (+0.60), AMED: 26.82 (unch), HLS: 46.76 (+0.05), MD: 73.41 (+0.35)

DaVita Issues 5.00% Senior Notes Worth $1.5B Due 2025 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 5:01PM CDT
DaVita Healthcare Partners Inc. (DVA) recently issued 5.00% senior notes worth $1.5 billion, which are scheduled to mature in 2025.
CHE: 123.62 (+0.08), AFAM: 47.11 (+1.80), DVA: 83.91 (+0.50), ADUS: 28.86 (+0.41)

DaVita sets price of upsized debt offering
Seeking Alpha - at Seeking Alpha - Wed Apr 15, 8:48AM CDT

DVA: 83.91 (+0.50)

DaVita Kidney Care Receives ERE Recruiting Excellence Awards for Military Talent Program and Best Employee Referral Program
PR Newswire - Wed Apr 15, 5:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, received the ERE Recruiting Excellence Military Talent Program and Best Employee Referral Program Awards for its exemplary recruiting efforts.
DVA: 83.91 (+0.50)

DaVita HealthCare Partners Inc. Announces Upsizing and Pricing of Senior Notes Offering
PR Newswire - Tue Apr 14, 4:58PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) (the "Company" announced today the upsizing and pricing of its previously announced offering of senior notes due 2025 (the "Senior Notes". The principal amount of the Senior Notes was increased from $1.25 billion to $1.5 billion, and the Senior Notes were priced at 100.00% of their face amount to yield a 5.00% coupon. The offering is expected to close on April 17, 2015, subject to satisfaction of customary closing conditions.
DVA: 83.91 (+0.50)

DaVita initiates $1.25B debt offering
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 9:09AM CDT

DVA: 83.91 (+0.50)

DaVita HealthCare Partners Inc. Commences Cash Tender Offer For Any And All Of Its 6 5/8% Senior Notes Due 2020
PR Newswire - Tue Apr 14, 8:05AM CDT
DaVita HealthCare Partners Inc. (NYSEVA) (the "Company" today announced that it has commenced a tender offer to purchase for cash (the "Tender Offer" any and all of its outstanding 6 5/8% Senior Notes due 2020 (the "Notes". The Tender Offer is being made pursuant to an Offer to Purchase (the "Offer to Purchase" and the related Letter of Transmittal (the "Letter of Transmittal", each dated April 14, 2015.
DVA: 83.91 (+0.50)

DaVita HealthCare Partners Inc. Announces Offering of $1.25 Billion Senior Notes
PR Newswire - Tue Apr 14, 8:05AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) (the "Company" today announced that it intends to offer, subject to market and other conditions, $1.25 billion principal amount of senior notes due 2025 (the "Senior Notes".
DVA: 83.91 (+0.50)

DaVita HealthCare Partners Recognized as Top Workplace by The Denver Post
PR Newswire - Tue Apr 14, 5:24AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, announced that the company was recognized as a 2015 Top Workplace by The Denver Post. This is the fourth consecutive year the company has appeared on the list.
DVA: 83.91 (+0.50)

DaVita HealthCare Partners Inc. Schedules Capital Markets Day and 1st Quarter 2015 Investor Conference Call
PR Newswire - Mon Apr 13, 7:30AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its Capital Markets Day and first quarter 2015 earnings call in New York City on Tuesday, May 5, 2015, from 9:00 a.m. to 11:30 a.m. Eastern Time. The company plans to release its first quarter results the evening before.
DVA: 83.91 (+0.50)

My Top Health Care Provider And Service Stocks For 2015
Stan Stafford - at Seeking Alpha - Sat Apr 11, 11:31PM CDT

ACHC: 72.60 (+0.22), ACET: 20.17 (+0.19), CTRX: 59.56 (+0.05), MCK: 229.20 (+0.09), BRLI: 35.23 (+0.22), IPCM: 52.25 (-0.31), HLS: 46.76 (+0.05), SEM: 15.52 (+0.22), CI: 130.66 (+0.09), CNC: 73.67 (+1.13), HCA: 77.74 (+0.30), USPH: 47.92 (-0.03), DVA: 83.91 (+0.50), ADUS: 28.86 (+0.41), WCG: 83.50 (+0.31), MD: 73.41 (+0.35), PINC: 38.00 (+0.01)

Seeking Alpha's Biotech Weekly: A Biogen Deep Dive, Eisai's Arena Shuffle, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Apr 10, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 401.71 (-28.57), SPHS: 0.80 (-0.03), ADMS: 17.70 (-0.03), TKMR: 18.75 (-0.25), CBYL: 7.45 (-0.11), HPTX: 45.97 (-0.11), QURE: 26.09 (-0.28), SHPG: 255.11 (-0.26), SRPT: 13.42 (-0.24), HZNP: 31.75 (+0.97), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), ABBV: 66.07 (+1.82), CBMG: 29.51 (-1.85), ARNA: 4.49 (+0.05), EXEL: 3.08 (-0.02), ADXS: 23.34 (-0.27), PTLA: 38.51 (-0.85), BMY: 65.80 (-0.20), OCUL: 25.36 (-1.12), NVO: 56.65 (+0.44), DVA: 83.91 (+0.50), HALO: 16.86 (-0.08), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), AZN: 71.79 (-1.34), ALXN: 180.08 (-4.50), NVS: 104.28 (-1.22)

InsiderInsights.com Daily Round Up 4/8/15: SNTA, VNCE, AGCO, EGLE
InsiderInsights - at Seeking Alpha - Wed Apr 08, 11:08PM CDT

EGLE: 8.50 (-0.19), FULL: 3.60 (-0.12), AGCO: 48.31 (-0.56), NXRT: 13.97 (+0.10), VNCE: 18.94 (-0.30), LM: 54.60 (+0.07), BURL: 54.35 (-0.84), SNTA: 2.69 (-0.28), DVA: 83.91 (+0.50), OHI: 38.53 (+0.24), CFG: 25.57 (-0.07), SIX: 51.08 (+1.20), TOL: 36.80 (+0.75), AAPL: 130.28 (+0.61), BRX: 24.63 (-0.01), ALCO: 47.11 (-0.65)

2016 Medicare Advantage benchmark rate may slice $50M off DaVita's operating income
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 6:43AM CDT

DVA: 83.91 (+0.50)

InsiderInsights.com Daily Round Up 3/30/15: VEEV, VNCE, PRSS, OGS
InsiderInsights - at Seeking Alpha - Tue Mar 31, 9:55AM CDT

GIII: 118.53 (+1.90), KIRK: 24.35 (+0.50), LNG: 77.29 (-1.35), VNCE: 18.94 (-0.30), UE: 23.40 (-0.09), AET: 108.82 (-0.08), VEEV: 27.17 (-0.24), PRSS: 3.98 (+0.10), WIW: 11.55 (+0.04), DVA: 83.91 (+0.50), PRE: 129.04 (unch), ARMK: 31.66 (+0.20), CPF: 22.80 (-0.38), FSB: 20.90 (+0.15), PHII: 31.74 (-0.26), RIT: 13.04 (unch), ICPT: 283.20 (-2.22), OGS: 43.00 (+0.52), ALCO: 47.11 (-0.65), WIA: 11.69 (+0.03)

DaVita Kidney Care Dietitians and Social Workers Celebrated for Distinctive Roles in Patient Care
PR Newswire - Mon Mar 30, 5:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, is celebrating its more than 3,600 dietitians and social workers during March for their distinctive and important roles in patient care.
DVA: 83.91 (+0.50)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading